Skip to main content
S 3733 118th Congress Senate Health Administrative law and regulatory procedures Civil actions and liability Congressional oversight Department of Health and Human Services Health programs administration and funding Health promotion and preventive care Organ and tissue donation and transplantation

Shandra Eisenga Human Cell and Tissue Product Safety Act

Introduced: February 5, 2024 Introduced by: Peters, Gary C. Democratic · Michigan See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 5, 2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Feb 5, 2024
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Shandra Eisenga Human Cell and Tissue Product Safety Act

This bill requires the Department of Health and Human Services (HHS) to educate the public and health care providers about the benefits and risks of transplants that use human cell or tissue products, including the risk of infections.

HHS must develop the educational campaign after taking into consideration information about products that carry the highest risk of transmitting infections to transplant recipients. HHS may award grants to other entities to conduct public awareness initiatives and media campaigns about the risk of infections. 

The bill also establishes specific civil penalties for violations of laws regarding the spread of communicable diseases and regulations regarding procedures for human cell or tissue products.

What's happening now February 5, 2024

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
  • HR 7188 Identical bill Shandra Eisenga Human Cell and Tissue Product Safety Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 3733: Shandra Eisenga Human Cell and Tissue Product Safety Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-3733/
MLA
"S. 3733: Shandra Eisenga Human Cell and Tissue Product Safety Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-3733/.
Bluebook (legal)
S. 3733, 118th Cong. (2026), https://openamerica.io/bill/118-S-3733/.
Markdown link
[S. 3733: Shandra Eisenga Human Cell and Tissue Product Safety Act](https://openamerica.io/bill/118-S-3733/)
Report a problem